| Cash Flow | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2024-10-31 |
|---|---|---|---|---|
| Net loss | -156,811 | -88,378 | -40,018 | -193,237 |
| Allowance for expected credit losses | 1,592 | 1,193 | 1,027 | 1,025 |
| Depreciation and amortization | 15,918 | 10,109 | 4,963 | 12,730 |
| Amortization of deferred contract acquisition costs | 20,805 | 13,769 | 6,691 | 19,189 |
| Stock-based compensation expense | 165,067 | 110,321 | 48,167 | 160,702 |
| Net accretion of discount on marketable securities | 1,717 | 1,278 | 736 | 4,646 |
| Non-cash lease expense | 13,688 | 9,122 | 4,540 | 13,528 |
| Impairment of long-lived assets | 30,716 | - | - | 0 |
| Amortization of discount on revolving credit facility and term loan issuance costs | 91 | 60 | 30 | 91 |
| Accounts receivable | -14,376 | -17,767 | -18,738 | -20,610 |
| Prepaid expenses and other current assets | 24,711 | 20,179 | 8,846 | 15,852 |
| Other assets | -561 | -274 | 714 | 4,594 |
| Accounts payable | 2,609 | 6,261 | -1,724 | 4,610 |
| Accrued expenses and other liabilities | -4,836 | -12,170 | -7,442 | -11,408 |
| Deferred revenue | 2,326 | 10,820 | -12,512 | 10,920 |
| Operating lease liabilities | -16,903 | -11,092 | -5,400 | -14,598 |
| Net cash provided by (used in) operating activities | 62,771 | 46,599 | 6,764 | -930 |
| Purchases of marketable securities | 161,077 | 104,096 | 34,055 | 166,628 |
| Sales of marketable securities | - | - | - | 0 |
| Maturities of marketable securities | 165,576 | 96,576 | 41,000 | 195,605 |
| Purchases of property and equipment | 2,604 | 1,935 | 638 | 4,064 |
| Capitalized internal-use software costs | 7,361 | 5,287 | 2,131 | 4,702 |
| Net cash (used in) provided by investing activities | -5,466 | -14,742 | 4,176 | 20,211 |
| Repayment of term loan | 3,750 | 2,500 | - | 1,875 |
| Repurchases of common stock | 74,183 | 43,398 | 14,526 | 73,869 |
| Proceeds from exercise of stock options | 2,835 | 2,073 | 1,257 | 3,884 |
| Proceeds from employee stock purchase plan | 13,012 | 7,746 | 7,746 | 13,665 |
| Taxes paid related to net share settlement of equity awards | 0 | 0 | 0 | 5 |
| Net cash used in financing activities | -62,086 | -36,079 | -5,523 | -58,200 |
| Effect of foreign exchange rates on cash, cash equivalents, and restricted cash | 3,795 | 4,030 | 3,799 | -656 |
| Net decrease in cash, cash equivalents, and restricted cash | -986 | -192 | 9,216 | -39,575 |
| Cash and cash equivalents at beginning of period | 184,864 | 184,864 | 184,864 | 236,663 |
| Cash and cash equivalents at end of period | 183,878 | 184,672 | 194,080 | 197,088 |
Asana, Inc. (ASAN)
Asana, Inc. (ASAN)